Bristol-Myers Squibb Completes Amira Pharmaceuticals Acquisition

Bristol-Myers Squibb (BMS) Company has completed its previously announced acquisition of  Amira Pharmaceuticals, a privately held small-molecule pharmaceutical company, focused on the discovery and early development of new drugs to treat inflammatory and fibrotic diseases.  As a result of the transaction, Amira Pharmaceuticals has now become a wholly-owned subsidiary of Bristol-Myers Squibb. The acquisition of

Continue Reading